Drug Use Review Board


The Drug Use Review Board (DUR) is a requirement of the Social Security Act, Section 1927. The DUR Board consists of 6 members, 3 physicians, and 3 pharmacists, appointed by the State Director of Health and Human Resources. 

The DUR Board meets quarterly to monitor drugs for:

  • therapeutic appropriateness 
  • over or under-utilization 
  • therapeutic duplications
  • drug-disease contraindications
  • quality care

The DUR Board does this by establishing prior authorization and quantity limits to certain drugs based on information, experience, and testimony presented at the DUR Board meetings. This includes retrospective evaluation of interventions, and prospective drug review that is done electronically for each prescription filled at the Point of Sale (POS).

Last Edited: 9/29/2017